<p>AngioDynamics Inc. held its Annual Meeting of Shareholders on November 10, 2025. At the meeting, shareholders elected James C. Clemmer and Michael E. Tarnoff, MD, to the Board of Directors. Shareholders also approved the ratification of Deloitte &amp; Touche LLP as the independent registered public accounting firm for the fiscal year ending May 31, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AngioDynamics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-25-041542), on November 12, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

ANGO

<p>AngioDynamics Inc. held its Annual Meeting of Shareholders on November 10, 2025, where shareholders elected James C. Clemmer and Michael E. Tarnoff, MD, to the Board of Directors. They also ratified Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending May 31, 2026.</p>

AngioDynamics Inc. Held Annual Shareholder Meeting